Research—Biology
The biology of the pathway Ruxton is pursuing is fairly well understood.
» Learn more about
glutamate excitotoxicity
» Learn more about
glutamate transporters
» Learn more about diseases that
are
glutamate mediated
Research—Chemistry
Ruxton is pursuing both previously marketed compounds from several
chemical classes as well as novel compounds. Novel compounds are
analogs of very positive hits from diversity screening.
Ruxton has developed a strong intellectual property suite and will
continue to build its position through patenting of novel chemical
series.
|